Hemostemix Inc. (Hemostemix) has announced the signing of a Global Master Services Agreement with My Next Health Inc. (MNH), and has, subject to TSXV approval, obtained a subscription from MNH in the amount of USD $150,000 at CAD $0.25 per Unit.
PRESS
Hemostemix Inc. (Hemostemix) has announced the signing of a Global Master Services Agreement with My Next Health Inc. (MNH), and has, subject to TSXV approval, obtained a subscription from MNH in the amount of USD $150,000 at CAD $0.25 per Unit.
Nurcapital Corporation Ltd. (Nurcapital), a capital pool company, and Green Sky Labs Inc. (GSL) today announced the execution of a definitive business combination agreement (the “Definitive Agreement”) which, subject to certain conditions and applicable TSX Venture Exchange (“TSXV”) approval, will result in the reverse takeover of Nurcapital by GSL and will constitute Nurcapital’s “Qualifying Transaction”, as defined by Policy 2.4 – Capital Pool Companies (“Policy 2.4”) of the TSXV (the “Proposed Qualifying Transaction”).
